Green Thumb Industries (GTBIF) Total Debt (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly Total Debt came in at $266.3 million in Q1 2026, up 86.91% YoY from $142.5 million in Q1 2025, and up 17.64% on a QoQ basis from $226.4 million in Q4 2025.
Green Thumb Industries (GTBIF) Total Debt (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of Total Debt data on file, last reported at $266.3 million in Q1 2026.
- Quarterly Total Debt rose 86.91% year-over-year to $266.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $266.3 million (up 86.91% YoY) and the FY2025 annual result came in at $226.4 million, down 11.2% from the prior year.
- Total Debt advanced to $266.3 million in Q1 2026, from $226.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $306.9 million in Q1 2024 to a low of $82.5 million in Q2 2024.
- A 5-year average of $251.5 million and a median of $263.9 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2024 — Total Debt tumbled 71.45% — and 2025, when it soared 203.05%.
- Tracing GTBIF's Total Debt over 5 years: stood at $286.0 million in 2022, then grew by 6.82% to $305.5 million in 2023, then slipped by 16.55% to $255.0 million in 2024, then dropped by 11.2% to $226.4 million in 2025, then advanced by 17.64% to $266.3 million in 2026.
- The last three Total Debt figures came in at $266.3 million (Q1 2026), $226.4 million (Q4 2025), and $230.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 283.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 283.01 Mn |
| Mar 31, 2026 | 266.34 Mn |
| Dec 31, 2025 | 226.40 Mn |
| Sep 30, 2025 | 230.19 Mn |
| Jun 30, 2025 | 249.95 Mn |
| Mar 31, 2025 | 142.50 Mn |
| Dec 31, 2024 | 254.96 Mn |
| Sep 30, 2024 | 255.58 Mn |
| Jun 30, 2024 | 82.48 Mn |
| Mar 31, 2024 | 306.90 Mn |
| Dec 31, 2023 | 305.53 Mn |
| Sep 30, 2023 | 297.08 Mn |
| Jun 30, 2023 | 288.86 Mn |
| Mar 31, 2023 | 288.18 Mn |
| Dec 31, 2022 | 286.03 Mn |
| Sep 30, 2022 | 266.63 Mn |
| Jun 30, 2022 | 263.38 Mn |
| Mar 31, 2022 | 263.93 Mn |
| Dec 31, 2021 | 289.44 Mn |
| Sep 30, 2021 | 273.91 Mn |